- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
DCW's Q2 PAT surged to ₹13.81 Cr (YoY turnaround) on ₹539.21 Cr revenue, with H1 PAT up 360% to ₹25.20 Cr. EBITDA jumped 51% YoY. Specialty Chemicals led growth; CPVC capacity expanded, and a 44.5 MW solar plant commissioned for cost efficiency. Balance sheet deleveraging continues.